Hwaseong-si, South Korea

Tae Kyun Kim


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Tae Kyun Kim

Introduction

Tae Kyun Kim, an accomplished inventor based in Hwaseong-si, South Korea, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, his work focuses on developing innovative compounds aimed at treating various medical conditions.

Latest Patents

Among Kim's latest breakthroughs are his patents on substituted aminopyridine compounds functioning as EGFR inhibitors. These compounds, along with their pharmaceutically acceptable compositions, demonstrate inhibition activity against specific mutated forms of the EGFR protein. His second notable patent involves pyrrolidine and piperidine compounds, including their preparation processes, pharmaceutical compositions, and therapeutic uses. These compounds are particularly beneficial in the treatment and prevention of diseases mediated by Familial Adenomatous Polyposis (FAP).

Career Highlights

Tae Kyun Kim has worked with several prominent companies in the pharmaceutical industry, including Yuhan Corporation and Janssen Biotech, Inc. His experience in these organizations has allowed him to hone his skills in drug development and innovation, contributing to his success as an inventor.

Collaborations

Throughout his career, Kim has collaborated with notable professionals such as Ji Yeong Gal and Hyoung Sig Seo. These partnerships have helped propel his innovative ideas into practical applications, enhancing the potential impact of his inventions on healthcare.

Conclusion

Tae Kyun Kim's work embodies the spirit of innovation in pharmaceuticals. His patents reflect a strong commitment to advancing medical science, providing new avenues for the treatment and prevention of serious diseases. With a promising career ahead, Kim continues to be a key figure in the realm of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…